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Background: Juvenile idiopathic arthritis (JIA) is a heterogeneous disease that frequently affects also the
temporomandibular joint (TMJ) and associated structures. The main aim of this observational study was to describe
systematically orofacial clinical signs and subjective symptoms in JIA patients, classified according to the
International League of Associations for Rheumatology (ILAR) criteria, and to relate the findings to disease activity
and radiological TMJ condyle lesions.
Methods: The study was a retrospective evaluation of dental and medical records in consecutive JIA patients referred to
one of three dental specialist clinics in Sweden during an eight-year period. Data concerning temporomandibular signs,
symptoms and general disease activity were collected and condylar alterations were judged on panoramic radiographs.
Results: All ILAR categories of JIA were represented among the 266 referrals included in the study. The distribution of
patients among categories resembled the pattern seen in epidemiological studies. Persistent oligoarthritis was the largest
category with 36.5% of the patients. Temporomandibular clinical signs (mild, moderate or severe) occurred in 57.7% to
92.0%, and subjective symptoms (mild or severe) in 32.0% to 76.0% of the patients in all categories. Patients in the
juvenile psoriatic arthritis category had the largest number of orofacial signs and symptoms, and patients in the persistent
oligoarthritis category had the fewest signs and symptoms. There were significant associations between clinical signs as
well as subjective symptoms and overall disease activity. Half of all the patients had undergone panoramic examinations
and 37.9% of those were judged to have condylar alterations after a mean of 2.9 years after onset. No associations
between radiological findings and variables, such as signs, symptoms or disease activity, were found.
Conclusions: Temporomandibular signs and symptoms can be expected to a varying degree, including severe cases, in
all JIA categories. Clinical and subjective orofacial involvement appears to be related to disease activity but not to
condylar lesions.
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Juvenile idiopathic arthritis (JIA) is a generic term for
arthritis with unknown etiology and with the onset occur-
ring before the age of 16 [1]. The incidence in Sweden is
approximately 15 in 100 000 [2,3]. The classifications of
the disease have varied over time and in different parts of* Correspondence: anna-lena.cedstromer@odontologi.gu.se
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distribution, and reproduction in any mediumthe world, making comparisons between patients and dis-
ease characteristics difficult. In 1995, the new classification
criteria for JIA, the so-called International League Against
Rheumatism (ILAR) criteria, were proposed [1,4]. The
ILAR classification is currently used worldwide based on
clinical features, heredity and laboratory data.
The inflammation of the musculoskeletal system in
JIA has many different clinical expressions. All joints, in-
cluding the temporomandibular joint (TMJ), may be af-
fected. Pain from the jaws during function and rest may
be prominent in JIA as well as limited opening capacity,ntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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TMJ and associated muscles [5]. One or both TMJs may
thus be involved in JIA, sometimes without clinical or
subjective expression, which may cause delay of detec-
tion [6]. The TMJ may also be the only affected joint
[7]. TMJ involvement is thought to occur during the ac-
tive phase of JIA, when the inflammation generates
chondral and subchondral bone lesions and the conse-
quences for mandibular growth and development may
be considerable, regardless of whether or not there are
signs and symptoms [8].
The prevalence of signs, symptoms and radiological
findings in the masticatory system in patients with JIA
has varied between 17% and 87% in previous studies
[9-15]. The number of examined subjects has often been
limited. The disparity may be due not only to large vari-
ations in patient sample composition but also to the
examination methods used.
Clinical findings and subjective complaints in the oro-
facial area in young JIA patients, classified according to
the now generally applied ILAR criteria, have not been ex-
tensively defined, and the relationship between orofacial
engagement and disease activity and radiographic changes
in the TMJ has not been determined. The main aim was
therefore to describe systematically the clinical and sub-
jective involvement of the TMJ and associated structures
in pediatric patients diagnosed with JIA, categorised
according to the ILAR criteria, and referred to dental spe-
cialist clinics. Another aim was to relate orofacial signs
and symptoms to disease activity and to condylar alter-
ations, as assessed on panoramic radiographs.
Methods
All consecutive patients who fulfilled the ILAR criteria of
JIA [1] and who were referred by physicians or dentists
during an eight-year period to one of three specialist den-
tal clinics in Sweden were included. The participating
clinics were the Department of Surgical Sciences, Oral
and Maxillofacial Surgery in Uppsala, the Orofacial Pain
Specialist Clinic in Gothenburg and the Department of
Clinical Oral Physiology at the Eastman Institute in
Stockholm. Data were collected from the first examination
by the specialist dentist (study visit), which took place be-
tween January 1, 1999, and December 31, 2006. Eligible
patients had to be born after January 1, 1986, since they
were covered by free dental care and therefore more likely
to come to examination.
A systematic clinical assessment, according to struc-
tured protocols, of orofacial signs was made by a specialist
dentist at the study visit. Anamnestic information related
to patient-reported symptoms was likewise collected with
standardized questions to the patient and/or parents/
carers on the same occasion. One dentist (A-L C) read the
evaluations by the specialist dentists retrospectively, andHelkimo’s indices [16] were calculated on the basis of the
clinical and anamnestic data. Helkimo’s clinical dysfunction
index, Di 0-III, evaluates mandibular mobility, TMJ func-
tion, muscle pain, TMJ pain and pain on movement of the
mandible on a three-point scale of increasing severity; 0, 1
or 5. The sum, 0–25 points, constitutes the dysfunction
score, which forms the basis of the clinical dysfunction
index. The signs found at the clinical examination can thus
be expressed as Di 0 (0 points, no signs), Di I (1–4 points,
mild signs), Di II (5–9 points, moderate signs), or Di III
(10–25 points, severe signs). Anamnestic data relating to
subjective symptoms, the Helkimo’s anamnestic index, Ai
0-II, summarize TMJ sounds, fatigue/stiffness of the jaw,
pain, difficulty of jaw movements, locking and luxation. Ai
0 denotes the complete absence of subjective symptoms
and Ai I denotes mild symptoms, such as joint sounds, stiff-
ness or fatigue of the jaws. Ai II denotes severe symptoms,
with one or more of the following reported in the anam-
nesis: difficulty opening the mouth wide, locking, luxation
or pain on movement, facial and jaw pain.
Data were also collected by the same dentist from the
medical records at the pediatric rheumatology clinics
where the participating patients were treated. Interpret-
ation of all medical data was supervised by one pediatric
rheumatologist (LB). The JIA patients were classified
retrospectively according to the 2004 ILAR criteria [1].
The general disease activity during the last two years be-
fore the study visit was recorded. A modified version of
The European League Against Rheumatism (EULAR) cri-
teria, as presented by Andersson-Gäre [17], was used. One
further category was added, yielding a modified version of
five categories, where EU 1 denoted active disease (increas-
ing number of engaged joints), EU 2 denoted stable disease
(unchanged number of engaged joints), EU 3 denoted an
inactive disease with treatment (no disease activity with
treatment), EU 4 denoted an inactive disease without treat-
ment (no disease activity and no treatment less than two
years), and EU 5 denoted remission of the disease (no dis-
ease activity and no treatment for more than two years).
The presence or absence of any condylar alterations,
morphologic (flattening, osteophyte) or structural (ero-
sion, sclerosis, subchondral cysts), was evaluated on pano-
ramic radiographs. The dichotomous assessment was
made by one dentist (A-LC), blinded to all other informa-
tion, together with an oral radiology specialist, until con-
sensus; all on one occasion.
The multicenter study was approved by the Ethical
Committee at the University of Gothenburg, Göteborg,
Sweden (342–07).
Statistics
For comparisons of Di, Ai and EU between study clinics
and all eight categories, the Kruskal-Wallis test was used.
In order to test the difference between every two categories,
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test was used. For comparison of gender and age between
all sites, the Pearson chi-square test and the Kruskal-Wallis
test were used, respectively. For comparison between every
two categories of gender and age, Fisher’s exact test and the
Mann–Whitney u-test were used, respectively. Spearman’s
rank correlation was used for the correlation analysis. Two-
tailed statistical analyses were performed at a significance
level of P < 0.05, unless otherwise stated.
Results
The total number of referrals during the study period
was 278. Due to remission or missing medical data at
the time of the first dental specialist examination, 12 of
the 278 referrals could not be classified and, conse-
quently, 266 patients were included in the study.
Twenty-six of the participants were examined in Uppsala,
53 in Gothenburg and 199 in Stockholm. One specialist
dentist examined all the patients in Uppsala and one in
Stockholm, while several specialists examined the patients
in Gothenburg.
There were no differences among the patients between
the three study clinics with regard to gender distribution,
age at disease onset or at examination. Nor were there any
differences between sites with regard to summarized signs
and symptoms, Di and Ai. The dental specialist clinic in
Gothenburg had more patients with extended oligoarthritis
than the clinics in Stockholm and Uppsala (both P <
0.0001). The latter two sites had more patients than Goth-
enburg (both P < 0.0001) with persistent oligoarthritis. The
Stockholm clinic also had more patients with RF-negative
polyarthritis than Gothenburg (P < 0.0001). Patients at the
dental specialist clinic in Gothenburg had more active dis-
ease, EU 1, than the other clinics (P = 0.010). The clinic in
Gothenburg performed significantly fewer radiological ex-
aminations of their patients than the clinics in Uppsala and
Stockholm (both P < 0.0001).
The distribution of the 266 patients to the ILAR cat-
egories with respect to gender, mean age at disease onset
and disease duration at the study visit is shown in Table 1.
Among all patients at all sites, persistent oligoarthritis
made up the largest category, followed by RF-negative
polyarthritis.
Females dominated among all the included 266 pa-
tients, with an overall ratio of 3:1. The mean age at the
first specialist dental examination (study visit) was
10.0 years (7.4/13.1 in the 25/75th percentile).
The distribution of the dysfunction index, Di, and the
anamnestic index, Ai, respectively, among the patients in
the ILAR categories is shown in Figure 1. Clinical signs,
Di I-III (mild, moderate or severe), were found in 57.7% to
92.0% of the patients in the different ILAR categories, and
subjective symptoms, Ai I-II (mild or severe), in 32.0% to
76.0% of the patients. There were significant differencesbetween the JIA categories in both Di and Ai. Patients di-
agnosed with psoriatic arthritis had more clinical signs, Di,
than patients with extended oligoarthritis (P = 0.0028) and
RF-negative polyarthritis (P = 0.0138). Patients with psori-
atic arthritis also reported more subjective symptoms, Ai,
than patients with persistent oligoarthritis (P < 0.0001) and
extended oligoarthritis (P = 0.040). Clinical signs, Di, were
less common in the persistent oligoarthritis category com-
pared with systemic arthritis (P = 0.0444)), RF-negative
polyarthritis (P = 0.0076), RF-positive polyarthritis (P =
0.0180), and psoriatic arthritis (P < 0.0001). Patients with
persistent oligoarthritis also reported fewer symptoms, Ai,
than patients with undifferentiated arthritis (P = 0.0191)
and RF-negative arthritis (P = 0.015). The psoriatic cat-
egory therefore had the most orofacial signs and symp-
toms, according to Helkimo’s indices, while patients
diagnosed with persistent oligoarthritis had the fewest.
The correlation between clinical signs, Di, and subject-
ive symptoms, Ai, was rs = 0.57 (P < 0.001).
Among all patients, 76.0% had a disease activity of 1 or 2,
Figure 2. There were significant differences between cat-
egories in disease activity, summarized for the last two
years. Patients with systemic arthritis had more disease ac-
tivity, EU 1, than patients with persistent oligoarthritis (P =
0.0034), extended oligoarthritis (P = 0.0201), RF-negative
polyarthritis (P = 0.0395) and psoriatic arthritis (P = 0.0310).
Patients with extended oligoarthritis had less disease activ-
ity than psoriatic arthritis (P = 0.0361).
Clinical signs, Di, was significantly associated with dis-
ease activity, EU, rs = −0.13 (P = 0.0310). The association
between subjective symptoms, Ai, and disease activity was
also significant, rs = −0.18 (P = 0.0044).
In half of the patient cohort, a panoramic examination
was performed at the study visit (n = 134). There were no
differences in the proportion of radiological examinations
between categories, gender, age at onset or age at examin-
ation, Di or Ai. In patients with disease activity EU 2,
radiological examinations were performed more often than
in other groups (P = 0.0243). Four of the panoramic radio-
graphs were judged as “unreadable”. Of the remaining ra-
diographs in 130 patients, 48 (37.0%) were rated as having
a condylar alteration. The distribution of Di, Ai and con-
dylar alterations among the ILAR categories is shown in
Table 2. No significant association between condylar alter-
ations and category was observed. Nor were any significant
associations between condylar alterations and gender, age
at onset, age at examination, clinical signs (Di), subjective
symptoms (Ai) or disease activity found.
Discussion
This study collected data related to clinically recorded
orofacial signs and patient-reported subjective symptoms
in a comprehensive cohort of patients with JIA, referred
for specialist dental examination, at a mean of 2.9 years
Table 1 Distribution of gender, age at disease onset, and disease duration in 266 patients with JIA allocated to the ILAR categories






n (% girls) 266 (76) 5 (40) 97 (77) 38 (82) 68 (81) 15 (93) 25 (76) 5 (40) 13 (38)
Onset age, mean, 25/75th percentile yrs 7.1 (3.0/10.7) 3.3 (2.1/3.9) 6.1 (2.2/9.5) 5.7 (2.6/8.1) 7.4 (3.5/10.6) 11.9 (9.9/14.4) 8.8 (5.0/12.9) 11.1 (10.1/12.5) 9.5 (7.3/11.7)
Mean disease duration at study visit,
25/75th percentile yrs






























Di 0 = No signs Di I = Mild signs Di II = Moderate signs Di III = Severes signs
Ai 0 = No symtoms Ai I = Mild symtoms Ai II = Severe symtoms
n=97 n=38 n=68 n=15 n=25n=5 n=5 n=13










Figure 1 Distribution of clinical signs, Di and symptoms, Ai. Distribution (%) by Helkimo’s dysfunction index, Di 0-III and Helkimo’s
anamnestic index, Ai 0-II, of 266 JIA patients allocated to the ILAR categories. Di 0 denotes clinically no signs, Di I mild, Di II moderate, and Di III
severe signs of dysfunction of the masticatory system. Ai 0 denotes complete absence of subjective symptoms, Ai I mild, and Ai II severe
symptoms of the masticatory system.
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during the last two years were assessed. Panoramic ra-
diographs performed at the study visit, were available for
half of all patients. Records from three clinics, with geo-
graphically distinct catchment areas and with patients
referred over a period of several years, were examined to
ensure accuracy. Orofacial signs and symptoms were
common, varied between categories, and were related to
the disease activity. Condylar alterations were not associ-
ated with other variables, such as ILAR category, clinical
signs, symptoms or disease activity.
A strength of the study was the fairly large cohort, with
objective as well as subjective variables involved and with
radiological findings as an end point. What percentage of
all patients diagnosed with JIA that was referred for
orofacial issues is not known. Although the cohort of re-
ferrals was relatively sizeable, in contrast with many previ-
ously described case series, the number of patients in
some of the ILAR categories was small, which weakens
the results. Above all, the basic data were not population-
based, were collected retrospectively and only discussed in
relation to previous studies. Register studies, like the
present one, run the risk of selection bias with overrepre-
sentation of severe cases possibly illustrated by the high
disease activity among the referrals. Although only
one dentist summarized the standardized clinical andanamnestic protocols, a group of experienced but non-
calibrated examiners were involved in the original data
collection. This implies a weakness, in terms of both valid-
ity and reliability.
Some differences in patient characteristics between the
sites were observed, partly reflecting variations in clinical
routines. The merged study cohort was representative of
the ILAR categories, gender and age in a distribution re-
sembling cohorts from epidemiological studies [3,18-20].
Different methods of collecting data regarding temporo-
mandibular signs and symptoms have been used over the
years. Helkimo’s dysfunction, Di, and anamnestic, Ai, indi-
ces are coarse quantifications of signs and symptoms in
the orofacial area, but the standardized evaluations facili-
tate comparisons between patients and conditions. The in-
dices have acceptable levels of reproducibility, not only for
the same observer but also between different observers
[16,21], and are strongly correlated with other indices [22].
Di and Ai have been widely used in epidemiological con-
texts concerning temporomandibular disorders (TMDs)
[23], also among children and adolescents [24].
TMDs with signs and symptoms similar to those in JIA
also occur in the healthy, general population. Signs and
symptoms have been found to be less frequent in children
than in adults in general [23]. Examination of randomly

















EU 5 = Remission EU 4 = Inactive without treatment EU 3 = Inactive with treatment EU 2 = Stable EU 1 = Active disease
n=5 n=97 n=38 n=68 n=15 n=25 n=5 n=13
Figure 2 Distribution of disease activity, EU. Distribution (%) of disease activity according to the modified European League Against
Rheumatism, EULAR (EU1-EU5) criteria, in 266 patients with JIA allocated to the ILAR categories. EU 1 denotes active disease (increasing number
of engaged joints), EU 2 denotes stable disease (unchanged number of engaged joints), EU 3 denotes an inactive disease with treatment (no
disease activity), EU 4 denotes an inactive disease without treatment (no disease activity and no treatment less than two years) and EU 5 denotes
remission of the disease (no disease activity and no treatment for more than two years).
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prevalence of severe TMD signs and symptoms [25]. Se-
vere clinical signs, Di, were rare, also in a longitudinal
series of Finnish children [26]. Signs of, at most, mild dys-
function have thus been found in only a few percent
among healthy, young children [27], but increase with age
[28-30]. The prevalence of self-reported TMD in a largeTable 2 Distribution of panoramic examinations, clinical sign





Panoramic examination,n(%) 130 3 (2) 50 (39) 9 (7)
Di 0 45(35) 1(33) 22(44) 4(44)
Di I 24(19) 1(33) 12(24) 0
Di II 44(34) 0 13(26) 3(33)
Di III 17(13) 1(33) 3(6) 2(22)
Ai 0 73(56) 1(33) 34(68) 7(78)
Ai I 11(9) 1(33) 4(8) 0
Ai II 46(35) 1(33) 12(24) 2(22)
Condylar alteration, n (%) 48 (37) 0 17 (34) 7 (78)cohort of Swedish youths, 12–19 years of age, was 4.2%
[31], and other studies have reported similar figures
[32,33]. Most of the patients in the present case series
were afflicted in the orofacial area. Cases with severe dys-
function, Di III, were found in all but one of the diagnostic
categories. Severe symptoms; Ai II, occurred in all categor-







36 (28) 9 (7) 13 (10) 2 (2) 8 (6)
12(33) 2(22) 1(8) 1(50) 2(25)
5(14) 3(33) 2(15) 0 1(13)
13(36) 3(33) 7(54) 1(50) 4(50)
6(17) 1(11) 3(23) 0 1(13)
19(53) 5(56) 3(23) 1(50) 3(38)
2(1) 1(11) 2(15) 0 1(13)
15(42) 3(33) 8(62) 1(50) 4(50)
9 (25) 6 (67) 7 (54) 0 2 (25)
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groups. Severe signs and symptoms among JIA patients,
according to Helkimo’s indices, have been presented earl-
ier but all the categories were not represented [34].
In the present study, the prevalence of orofacial signs, as
assessed by the specialist dentists, was higher than the
prevalence of self-reported orofacial symptoms in all JIA
categories, which is in agreement with epidemiological sur-
veys of TMD [23]. Patients may be unaware of, used to or
not disturbed by certain clinical findings. The significant
correlation between signs and symptoms, as found in the
present study, is supported by findings in other studies [23].
The distribution of clinical signs and reported orofacial
discomfort in this cohort differed significantly between
the ILAR categories. That differences exist are in line
with earlier investigations but the results have varied be-
tween studies. Pedersen et al. [10] found most TMJ in-
volvement in the polyarticular category, Twilt et al. [11]
in the systemic category and Cannizzaro et al. [13] in
the extended oligoarticular category. In the present
study, both signs and symptoms were significantly more
frequent in the psoriatic arthritis category than in several
other categories, despite similar disease activity. Clinical
signs were found in almost all psoriatic arthritis patients
and symptoms were also common. One reason may be
that psoriatic arthritis engages not only the synovium,
but also the surrounding tissues [35-37].
Moreover, the RF-positive category had very few patients
without any orofacial signs. It is known that the RF factor
contributes to joint involvement [10,11,38,39], but as the
number of patients in this category was limited, it is diffi-
cult to draw confident conclusions.
This study found significant associations between
orofacial signs and symptoms, assessed at the study visit,
and overall disease activity, assessed for the most recent
years. The findings were perhaps not unexpected, as the
TMJ is a joint among others and a high disease activity
affects articular as well as periarticular structures.
The radiographs mirror previous arthritis in contrast with
instant clinical and subjective examinations. Panoramic
radiography has obvious shortcomings in TMJ diagnostics.
Only condylar changes can be evaluated with any confi-
dence, and have acceptable reliability and specificity, but
low sensitivity compared with more advanced radiological
techniques [40]. For example, joint fluid and synovial en-
hancement can not be demonstrated with panoramic radi-
ography. Magnetic resonance imaging (MRI) is the most
superior technique to detect ongoing inflammation [12,15].
Orofacial signs and symptoms might be related to ongoing
inflammation but this is uncertain. However, panoramic ex-
aminations are simple, inexpensive, and easily accessible at
most clinics, involve low radiation levels and require no
sedation in young children. The method is used to get an
overview of the jaws and is often performed before moresophisticated imaging examinations are performed. The
reasons for the panoramic examinations in our study may
have varied and patients with higher disease activity were
examined more often, which entails a possible bias. The fre-
quency of condylar alterations in this study was somewhat
lower than previously reported for similar patient cohorts
[9,10], and were not related to any clinical or subjective var-
iables, ILAR category or disease activity over the last years.
Pedersen et al. [10], on the other hand, reported that con-
dylar resorption had the highest prevalence in children with
JIA of the polyarticular type as judged from panoramic ra-
diographs. The median disease duration in their study was
4.4 years. Also using panoramic radiographs in patients
with JIA, Billau et al. [9] found no relation between con-
dylar lesions, diagnostic category or disease activity after a
median disease duration of 2.96 years in agreement with
our results.
Conclusion
The need for prospective studies to find risk factors for
TMJ involvement have been emphasized [12] and the
findings of this study support that conclusion.
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